CO-EVOLVED MEDICINES

View On IPO.GOV.AU

Protected: Registered/protected

Last updated on 19 Oct 2021

Owner Info

Empress Therapeutics, Inc.

55 Cambridge Parkway, Suite 800E

Cambridge MA 02142, UNITED STATES OF AMERICA

Serial Number

2200158 filed on 8 Jun 2021

Correspondent

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.

600 Atlantic Avenue,

Boston MA 02210-2206,

UNITED STATES OF AMERICA

CO-EVOLVED MEDICINES

Classification Information

2200158

8 Jun 2021

8 Jun 2031

WORD

8 Dec 2020

Status Date	Action Taken
19^th Oct 2021	International Registration in Australia Protected correspondence sent
18^th Oct 2021	IP Right Registration Published
18^th Oct 2021	Status change to Registered/Protected
12^th Aug 2021	Application Accepted correspondence sent
11^th Aug 2021	IP Right has been Examined
11^th Aug 2021	IP Right Acceptance Published
11^th Aug 2021	Status change to Accepted
5^th Aug 2021	Awaiting examination
5^th Aug 2021	Examination expedited
5^th Aug 2021	Word and image indexing completed